XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
| (FY)2024/12/31 | (Q4)2024/12/31 | (Q3)2024/09/30 | (Q2)2024/06/30 | (Q1)2024/03/31 | (FY)2023/12/31 | (Q4)2023/12/31 | (Q3)2023/09/30 | (Q2)2023/06/30 | (Q1)2023/03/31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 資産 | ||||||||||
| 売却した現金、現金同等物及び連邦資金 | -6.34%4.53億 | -6.34%4.53億 | 1.91%4.84億 | 77.14%4.87億 | 30.77%5.15億 | 41.21%4.83億 | 41.21%4.83億 | 15.64%4.75億 | -32.20%2.75億 | -42.25%3.94億 |
| -現金及び現金同等物 | -6.34%4.53億 | -6.34%4.53億 | 1.91%4.84億 | 77.14%4.87億 | 30.77%5.15億 | 41.21%4.83億 | 41.21%4.83億 | 15.64%4.75億 | -32.20%2.75億 | -42.25%3.94億 |
| 営業債権、その他の債権及び契約資産 | -1.85%3,524.2万 | -1.85%3,524.2万 | 16.66%3,972.4万 | -13.66%3,513.7万 | 6.21%3,505万 | 27.19%3,590.7万 | 27.19%3,590.7万 | -49.54%3,405.1万 | 227.39%4,069.4万 | 274.00%3,300.2万 |
| -売掛金 | -1.85%3,524.2万 | -1.85%3,524.2万 | 16.66%3,972.4万 | -13.66%3,513.7万 | 6.21%3,505万 | 27.19%3,590.7万 | 27.19%3,590.7万 | -49.54%3,405.1万 | 227.39%4,069.4万 | 274.00%3,300.2万 |
| 正味貸付金 | 16.41%35.12億 | 16.41%35.12億 | 15.74%34.23億 | 9.65%33.22億 | 12.15%31.98億 | 15.75%30.17億 | 15.75%30.17億 | 18.70%29.58億 | 29.20%30.3億 | 48.11%28.52億 |
| -総貸付金 | 17.64%36.96億 | 17.64%36.96億 | 17.43%36.01億 | 10.50%34.78億 | 13.49%33.45億 | 16.92%31.41億 | 16.92%31.41億 | 19.88%30.66億 | 31.10%31.47億 | 49.54%29.47億 |
| -貸倒引当金及びリース損失引当金 | 51.33%1.77億 | 51.33%1.77億 | 68.44%1.7億 | 33.54%1.48億 | 56.25%1.39億 | 57.99%1.17億 | 57.99%1.17億 | 70.52%1.01億 | 124.41%1.11億 | 129.88%8,912.3万 |
| -不労所得 | 11.59%-645.4万 | 11.59%-645.4万 | 2.36%-721.1万 | -15.41%-774.2万 | -13.49%-746.2万 | -19.53%-730万 | -19.53%-730万 | -11.71%-738.5万 | -8.44%-670.8万 | 2.79%-657.5万 |
| 有価証券及び投資 | -63.81%5,812.1万 | -63.81%5,812.1万 | -61.29%5,937.7万 | -51.23%5,987.7万 | -46.33%6,067.3万 | 47.46%1.61億 | 47.46%1.61億 | 40.14%1.53億 | 2.14%1.23億 | -22.63%1.13億 |
| -売却可能金融資産 | 5.60%1,080万 | 5.60%1,080万 | -9.59%1,075.7万 | -11.41%1,066.4万 | -6.72%1,058.3万 | -3.11%1,022.7万 | -3.11%1,022.7万 | 12.45%1,189.8万 | 15.97%1,203.7万 | 14.25%1,134.6万 |
| -満期保有金融資産 | -7.03%4,728.6万 | -7.03%4,728.6万 | 14.18%4,858.2万 | 291.42%4,917.4万 | 1,250.85%5,004.9万 | 4,809.27%5,086万 | 4,809.27%5,086万 | 3,304.00%4,255万 | 896.27%1,256.3万 | 188.10%370.5万 |
| -短期投資 | -99.96%3.5万 | -99.96%3.5万 | -99.96%3.8万 | -99.96%3.9万 | -99.96%4.1万 | 2.25%9,950.4万 | 2.25%9,950.4万 | 1.35%9,893.9万 | -9.57%9,816.7万 | -27.35%9,799.9万 |
| 銀行が所有する生命保険 | 3.92%1,337.5万 | 3.92%1,337.5万 | 2.20%1,325.5万 | 2.01%1,313.2万 | 1.80%1,299.1万 | 1.60%1,287万 | 1.60%1,287万 | 3.13%1,297万 | 3.11%1,287.3万 | 3.39%1,276.1万 |
| 有形固定資産純額 | 16.52%3,265万 | 16.52%3,265万 | 17.21%3,126万 | 20.07%3,016.1万 | 25.87%2,875.1万 | 20.62%2,802.2万 | 20.62%2,802.2万 | 12.24%2,666.9万 | 3.65%2,511.9万 | -4.71%2,284.2万 |
| -有形固定資産総額 | -18.72%3,265万 | -18.72%3,265万 | 17.21%3,126万 | 20.07%3,016.1万 | 25.87%2,875.1万 | 16.49%4,017万 | 16.49%4,017万 | 12.24%2,666.9万 | 3.65%2,511.9万 | -4.71%2,284.2万 |
| -減価償却累計额 | ---- | ---- | ---- | ---- | ---- | -7.95%-1,214.8万 | -7.95%-1,214.8万 | ---- | ---- | ---- |
| その他の資産 | 13.84%1,364.6万 | 13.84%1,364.6万 | -16.48%1,171.1万 | 249.05%1,174.2万 | 281.28%1,207.5万 | 183.45%1,198.7万 | 183.45%1,198.7万 | 267.04%1,402.1万 | -91.14%336.4万 | -88.72%316.7万 |
| 資産合計 | 9.80%41.21億 | 9.80%41.21億 | 10.54%40.66億 | 12.06%39.62億 | 12.00%38.65億 | 19.36%37.53億 | 19.36%37.53億 | 17.38%36.78億 | 19.04%35.35億 | 21.78%34.51億 |
| 負債 | ||||||||||
| 顧客預金 | 6.69%35.85億 | 6.69%35.85億 | 10.26%36.27億 | 12.04%35.43億 | 11.88%34.63億 | 19.27%33.6億 | 19.27%33.6億 | 15.95%32.9億 | 17.25%31.63億 | 20.13%30.95億 |
| 未払金 | -12.77%3,013.3万 | -12.77%3,013.3万 | 2.48%4,025.8万 | 24.77%3,553.5万 | 7.86%3,415.6万 | 63.69%3,454.3万 | 63.69%3,454.3万 | 25,576.47%3,928.5万 | 8,530.30%2,848万 | 21,153.69%3,166.8万 |
| -買掛金 | -12.77%3,013.3万 | -12.77%3,013.3万 | 2.48%4,025.8万 | 24.77%3,553.5万 | 7.86%3,415.6万 | 63.69%3,454.3万 | 63.69%3,454.3万 | 25,576.47%3,928.5万 | 8,530.30%2,848万 | 21,153.69%3,166.8万 |
| 長期借入金及びリース債務 | -1.07%5,328.2万 | -1.07%5,328.2万 | -1.04%5,345.6万 | -0.81%5,363.1万 | 2.04%5,371.7万 | 1.96%5,385.8万 | 1.96%5,385.8万 | 61.51%5,401.6万 | 60.46%5,407.1万 | 55.07%5,264.1万 |
| -長期借入金 | 0.31%4,788.4万 | 0.31%4,788.4万 | 0.32%4,784.7万 | 0.32%4,781万 | 0.32%4,777.1万 | 0.31%4,773.4万 | 0.31%4,773.4万 | 70.76%4,769.5万 | 70.75%4,765.8万 | 70.72%4,761.9万 |
| -リース債務 | -11.85%539.8万 | -11.85%539.8万 | -11.26%560.9万 | -9.23%582.1万 | 18.40%594.6万 | 17.00%612.4万 | 17.00%612.4万 | 14.64%632.1万 | 10.84%641.3万 | -17.05%502.2万 |
| 従業員福利厚生費 | -30.69%33.2万 | -30.69%33.2万 | -28.07%36.9万 | -25.96%40.5万 | -24.05%44.2万 | -22.24%47.9万 | -22.24%47.9万 | -20.83%51.3万 | -19.56%54.7万 | -18.26%58.2万 |
| その他の負債 | 46.80%1,342.5万 | 46.80%1,342.5万 | 21.54%1,252万 | -30.09%1,185万 | -15.64%1,025.5万 | 2.61%914.5万 | 2.61%914.5万 | -69.43%1,030.1万 | -15.45%1,695.1万 | -16.47%1,215.6万 |
| 負債合計 | 6.48%36.83億 | 6.48%36.83億 | 10.02%37.34億 | 11.72%36.45億 | 11.57%35.62億 | 19.21%34.58億 | 19.21%34.58億 | 16.83%33.94億 | 18.55%32.63億 | 21.57%31.92億 |
| 資本 | ||||||||||
| 資本金 | 75.34%2.28億 | 75.34%2.28億 | 4.27%1.35億 | 3.64%1.33億 | 3.26%1.32億 | 3.42%1.3億 | 3.42%1.3億 | 4.28%1.29億 | 4.13%1.28億 | 3.96%1.27億 |
| -普通株式 | 75.34%2.28億 | 75.34%2.28億 | 4.27%1.35億 | 3.64%1.33億 | 3.26%1.32億 | 3.42%1.3億 | 3.42%1.3億 | 4.28%1.29億 | 4.13%1.28億 | 3.96%1.27億 |
| -優先株 | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| 利益剰余金 | 27.35%2.11億 | 27.35%2.11億 | 26.14%1.97億 | 25.80%1.84億 | 29.29%1.72億 | 37.76%1.65億 | 37.76%1.65億 | 46.24%1.56億 | 52.46%1.46億 | 55.51%1.33億 |
| 利益剰余金に影響しない損益 | 99.57%-2,000 | 99.57%-2,000 | 99.91%-1,000 | 99.88%-2,000 | 99.89%-2,000 | 79.91%-46.9万 | 79.91%-46.9万 | 47.73%-109.3万 | -25.15%-168.2万 | -557.09%-180.7万 |
| 株主資本 | 48.72%4.39億 | 48.72%4.39億 | 16.69%3.32億 | 16.15%3.17億 | 17.37%3.04億 | 21.14%2.95億 | 21.14%2.95億 | 24.36%2.84億 | 25.27%2.73億 | 24.45%2.59億 |
| 資本合計 | 48.72%4.39億 | 48.72%4.39億 | 16.69%3.32億 | 16.15%3.17億 | 17.37%3.04億 | 21.14%2.95億 | 21.14%2.95億 | 24.36%2.84億 | 25.27%2.73億 | 24.45%2.59億 |
| 通貨単位 | ドル | ドル | ドル | ドル | ドル | ドル | ドル | ドル | ドル | ドル |
| 会計基準 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| 監査意見 | -- | -- | -- | -- | -- | 説明付き保留意見 | -- | -- | -- | -- |
